Initial vancomycin taper for the prevention of recurrent Clostridium difficile infection
初始万古霉素逐渐减量以预防复发性艰难梭菌感染
基本信息
- 批准号:380399
- 负责人:
- 金额:$ 27.59万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Operating Grants
- 财政年份:2018
- 资助国家:加拿大
- 起止时间:2018-03-01 至 2020-03-01
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Clostridium difficile infection (CDI) is a diarrheal illness that often comes from taking antibiotics or being in the hospital. It affects 37,000 Canadians a year with an estimated cost of $281 million. CDI can cause complications such as hospital admiss
艰难梭菌感染(CDI)是一种慢性疾病,通常来自服用抗生素或住院。 它每年影响37 000名加拿大人,估计费用为2.81亿加元。CDI可导致并发症,如住院
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lee Todd C其他文献
Lee Todd C的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lee Todd C', 18)}}的其他基金
Expanding the Staphylococcus Aureus Network Adaptive Platform (SNAP^2)
扩展金黄色葡萄球菌网络自适应平台 (SNAP^2)
- 批准号:
474605 - 财政年份:2022
- 资助金额:
$ 27.59万 - 项目类别:
Operating Grants
Expanding the Staphylococcus Aureus Network Adaptive Platform (SNAP^2)
扩展金黄色葡萄球菌网络自适应平台 (SNAP^2)
- 批准号:
466322 - 财政年份:2022
- 资助金额:
$ 27.59万 - 项目类别:
Operating Grants
PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN)
PipEracillin Tazobactam 与 mERoPENem 对比治疗头孢菌素耐药肠杆菌 (PETERPEN) 引起的血流感染
- 批准号:
444369 - 财政年份:2021
- 资助金额:
$ 27.59万 - 项目类别:
Operating Grants
Reducing post-discharge adverse drug events amongst the elderly: a multi-centre electronic deprescribing intervention
减少老年人出院后药物不良事件:多中心电子处方干预
- 批准号:
345668 - 财政年份:2016
- 资助金额:
$ 27.59万 - 项目类别:
Operating Grants
相似海外基金
Development of a novel skin care method for prevention of recurrence of cellulitis in lymphedema
开发预防淋巴水肿蜂窝组织炎复发的新型皮肤护理方法
- 批准号:
23K18377 - 财政年份:2023
- 资助金额:
$ 27.59万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
The determination of T-cell fate by different tumor antigens and prevention of post-operative recurrence of lung cancer
不同肿瘤抗原决定T细胞命运及预防肺癌术后复发
- 批准号:
22H02934 - 财政年份:2022
- 资助金额:
$ 27.59万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
SUPERHYDROPHOBIC DRUG LOADED BUTTRESSES FOR PREVENTION OF LUNGTUMOR RECURRENCE
用于预防肺部肿瘤复发的超疏水载药支撑
- 批准号:
10331020 - 财政年份:2019
- 资助金额:
$ 27.59万 - 项目类别:
Development of a novel therapy targeting liver cancer stem cell-specific RAB3B gene for prevention of postoperative intrahepatic recurrence
开发针对肝癌干细胞特异性RAB3B基因的新疗法以预防术后肝内复发
- 批准号:
19K09218 - 财政年份:2019
- 资助金额:
$ 27.59万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
SUPERHYDROPHOBIC DRUG LOADED BUTTRESSES FOR PREVENTION OF LUNG TUMOR RECURRENCE
用于预防肺肿瘤复发的超疏水载药支撑
- 批准号:
10083724 - 财政年份:2019
- 资助金额:
$ 27.59万 - 项目类别:
SUPERHYDROPHOBIC DRUG LOADED BUTTRESSES FOR PREVENTION OF LUNGTUMOR RECURRENCE
用于预防肺部肿瘤复发的超疏水载药支撑
- 批准号:
10553156 - 财政年份:2019
- 资助金额:
$ 27.59万 - 项目类别:
Development of recurrence prevention method for herpes simplex virus infection
单纯疱疹病毒感染预防复发方法的开发
- 批准号:
19K22780 - 财政年份:2019
- 资助金额:
$ 27.59万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
gamma-OHPdG as a prognostic biomarker of HCC recurrence and its prevention
γ-OHPdG 作为 HCC 复发及其预防的预后生物标志物
- 批准号:
10475222 - 财政年份:2018
- 资助金额:
$ 27.59万 - 项目类别:
The effect of exercise training on the recurrence prevention in patients with takotsubo syndrome
运动训练对章鱼壶综合征患者预防复发的作用
- 批准号:
18K10763 - 财政年份:2018
- 资助金额:
$ 27.59万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of neurocognitive interventions for prevention of relapse/recurrence in major depressive disorder
开发用于预防重度抑郁症复发的神经认知干预措施
- 批准号:
18K13323 - 财政年份:2018
- 资助金额:
$ 27.59万 - 项目类别:
Grant-in-Aid for Early-Career Scientists














{{item.name}}会员




